Loading organizations...

§ Private Profile · Maastricht, Limburg, The Netherlands
Sterilization technology developer providing intelligent containers for medical device and pharmaceutical sterility in healthcare.
Ansana is a medical technology company that develops intelligent sterilization containers and in-line monitoring systems for surgical instrument reprocessing in the pharmaceutical and healthcare industries. Operating on a subscription-based business model, the enterprise primarily serves hospitals and ambulatory surgical centers to ensure regulatory compliance, patient safety, and equipment traceability. The organization operates as an NLC venture and has acquired exclusive rights to a global patent portfolio originally developed by Stryker Corporation. While specific financial metrics remain undisclosed, the executive team brings a combined 170 years of healthcare experience and 50 years of entrepreneurial background, including five successful previous exits. The leadership group includes Chief Commercial Officer Arnoud van den Berge, Chief Technology Officer Stef Vanquickenborne, and advisory board member Martin Wenderoth, formerly of B. Braun. Ansana was established by co-founder and Chief Executive Officer Dominique Surinx.
Ansana has raised $2.7M across 2 funding rounds.
Ansana has raised $2.7M in total across 2 funding rounds.
Ansana has raised $2.7M in total across 2 funding rounds.
Ansana's investors include LIOF, NLC Health Ventures.
Ansana has raised $2.7M across 2 funding rounds. Most recently, it raised $1.8M Other Equity in September 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 29, 2025 | $1.8M Venture Round | — | — | Announced |
| Dec 20, 2023 | $930K Seed | — | Liof, NLC Health Ventures | Announced |